Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for Breast Atypical Ductal Hyperplasia
11 locations incl. Tucson
Sponsor: National Cancer Institute (NCI)
Sex: Female·Age: 18 - 55
Code: NCT06184750·Phase 2·Recruiting